Viewing Study NCT04231851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2026-01-13 @ 11:18 PM
Study NCT ID: NCT04231851
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-15
First Post: 2020-01-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
Sponsor: University of California, Irvine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myelogenous Leukemia (AML) Due to Therapy View
None Acute Myeloid Leukemia With Myelodysplasia-Related Changes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Therapy-Related AML View
None AML with MDS related changes View